Back to top

Truist Financial Sticks to Their Hold Rating for Quest Diagnostics (DGX)

In a report released yesterday, David S Macdonald from Truist Financial maintained a Hold rating on Quest Diagnostics, with a price target of $250....

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Quest Diagnostics Incorporated (DGX)